Chief Business Officer
In 2017, Michael Cloonan earned a total compensation of $10,043,744 as Chief Business Officer at Sage Therapeutics.
|Ranking||586 out of 13,165|
Michael Cloonan's 2017 compensation ranked 586th out of 13,165 executive pay records tracked by us this year.
Michael Cloonan earned more than 95.5% of all executives tracked by us in 2018.
|Ranking||27 out of 1,094|
In the industry of pharmaceutical preparations, Michael Cloonan's 2017 pay ranked 27th, among 1,094 executive pay records.
Michael Cloonan earned more than 97.5% of executives in this industry.
|Non-Equity Incentive Plan||$170,016|
Cloonan received $9,439,278 in option awards, which accounts for 93.98% of total compensation.
Cloonan also received $125,000 in bonus, $170,016 in non-equity incentive plan, $301,795 in salary and $7,655 in other compensation.